Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 29, 2025
Identification and Characterization of Three Novel Biomarkers for Mixed/Cholestatic Drug-Induced Liver InjuryKosuke Saito, Tatehiro Kagawa, Keiji Tsuji, et al.
Metabolites|September 4, 2020
Plasma Lipid Profiling of Three Types of Drug-Induced Liver Injury in Japanese Patients: A Preliminary StudyKosuke Saito, Tatehiro Kagawa, Keiji Tsuji, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 26, 2015
No contribution of the ABCB11 p.444A polymorphism in Japanese patients with drug-induced cholestasisTatehiro Kagawa, Shunji Hirose, Yoshitaka Arase, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 11, 2021
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysisMakoto Chuma, Haruki Uojima, Nobuhiro Hattori, et al.
Cancers|January 30, 2020
Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaMakoto Chuma, Haruki Uojima, Kazushi Numata, et al.
Clinical and Experimental Gastroenterology|October 16, 2020
Safety and Efficacy of Lenvatinib Treatment in Child-Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter AnalysisKatsuaki Ogushi, Makoto Chuma, Haruki Uojima, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib TreatmentMakoto Chuma, Hideki Yokoo, Atsushi Hiraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 3, 2020
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysisMakoto Chuma, Haruki Uojima, Atsushi Hiraoka, et al.
Pageof 5